← Back to the catalogue
Microbial and dietary metabolism
Propionate
Short-chain fatty acid involved in hepatic gluconeogenesis and gut–liver metabolic signalling.
Application contexts
- Metabolism and nutrition
- Microbiota and host interaction
Matrices
- Faeces
- Serum or plasma
Related techniques
- ¹H-NMR
Related publications
- Healthy lifestyle, metabolomics and incident type 2 diabetes in a population-based cohort from Spain. 2022 · The international journal of behavioral nutrition and physical activity · 38 citations · Panel: NMR low-molecular-weight metabolites
- Biological Response to Meal Ingestion: Gender Differences. 2019 · Nutrients · 26 citations · Panel: NMR low-molecular-weight metabolites
- The multiomics blueprint of the individual with the most extreme lifespan. 2025 · Cell reports. Medicine · 23 citations · Panel: NMR low-molecular-weight metabolites
Show 25 more Show less
- Lipidomic and metabolomic changes in community-acquired and COVID-19 pneumonia. 2024 · Journal of lipid research · 22 citations · Panel: NMR low-molecular-weight metabolites
- Serum branch-chained amino acids are increased in type 2 diabetes and associated with atherosclerotic cardiovascular disease. 2023 · Cardiovascular diabetology · 19 citations · Panel: NMR low-molecular-weight metabolites
- Multifaceted Analysis of Cerebrospinal Fluid and Serum from Progressive Multiple Sclerosis Patients: Potential Role of Vitamin C and Metal Ion Imbalance in the Divergence of Primary Progressive Multiple Sclerosis and Secondary Progressive Multiple Sclerosis. 2023 · Journal of proteome research · 19 citations · Panel: NMR low-molecular-weight metabolites
- Unravelling and Quantifying the "NMR-Invisible" Metabolites Interacting with Human Serum Albumin by Binding Competition and T2 Relaxation-Based Decomposition Analysis. 2017 · Journal of proteome research · 19 citations · Panel: NMR low-molecular-weight metabolites
- Gene-environment interaction analysis of redox-related metals and genetic variants with plasma metabolic patterns in a general population from Spain: The Hortega Study. 2022 · Redox biology · 14 citations · Panel: NMR low-molecular-weight metabolites
- Meal Enjoyment and Tolerance in Women and Men. 2019 · Nutrients · 14 citations · Panel: NMR low-molecular-weight metabolites
- Similarity network fusion to identify phenotypes of small-for-gestational-age fetuses. 2023 · iScience · 10 citations · Panel: NMR low-molecular-weight metabolites
- NMR-based metabolomic profiling identifies inflammation and muscle-related metabolites as predictors of incident type 2 diabetes mellitus beyond glucose: The Di@bet.es study. 2023 · Diabetes research and clinical practice · 10 citations · Panel: NMR low-molecular-weight metabolites
- Microbiota Shape Metabolic and Immune Determinants of CAR-T Therapy and Correlate with Outcomes in Myeloma. 2025 · Blood cancer discovery · 8 citations · Panel: NMR low-molecular-weight metabolites
- Metabolomic signature of the postprandial experience. 2018 · Neurogastroenterology and motility · 8 citations · Panel: NMR low-molecular-weight metabolites
- Traffic Density Exposure, Oxidative Stress Biomarkers and Plasma Metabolomics in a Population-Based Sample: The Hortega Study. 2023 · Antioxidants (Basel, Switzerland) · 7 citations · Panel: NMR low-molecular-weight metabolites
- Metabolomic patterns, redox-related genes and metals, and bone fragility endpoints in the Hortega Study. 2023 · Free radical biology & medicine · 7 citations · Panel: NMR low-molecular-weight metabolites
- Free triiodothyronine levels and age influences the metabolic profile and COVID-19 severity parameters in euthyroid and levothyroxine-treated patients. 2022 · Frontiers in endocrinology · 7 citations · Panel: NMR low-molecular-weight metabolites
- H-NMR metabolomics identifies three distinct metabolic profiles differentially associated with cardiometabolic risk in patients with obesity in the Di@bet.es cohort. 2024 · Cardiovascular diabetology · 6 citations · Panel: NMR low-molecular-weight metabolites
- ApoC-III proteoforms are associated with better lipid, inflammatory, and glucose profiles independent of total apoC-III. 2024 · Cardiovascular diabetology · 5 citations · Panel: NMR low-molecular-weight metabolites
- Multilayer metabolomic integration reveals bioenergetic disruption in Long COVID. 2026 · Journal of translational medicine · 4 citations · Panel: NMR low-molecular-weight metabolites
- Long-term mitochondrial and metabolic impairment in lymphocytes of subjects who recovered after severe COVID-19. 2025 · Cell biology and toxicology · 4 citations · Panel: NMR low-molecular-weight metabolites
- Fecal metabolomics to understand intestinal dysfunction in male dairy beef calves at arrival to the rearing farm. 2025 · Scientific reports · 2 citations · Panel: NMR low-molecular-weight metabolites
- Ketone Bodies Are Potential Prognostic Biomarkers in Relapsed/Refractory Diffuse Large B-Cell Lymphoma: Results from the R2-GDP-GOTEL Trial. 2025 · Cancers · 2 citations · Panel: NMR low-molecular-weight metabolites
- Assessment of physical status and analysis of lipidomic and metabolomic alterations in patients with Post-COVID-19 condition. 2026 · PloS one · 1 citation · Panel: NMR low-molecular-weight metabolites
- Initiating Empagliflozin and Sacubitril/Valsartan Early After Acute Myocardial Infarction: Mechanistic Study. 2025 · Journal of the American Heart Association · 1 citation · Panel: NMR low-molecular-weight metabolites
- Cardiovascular risk and metabolomic profile in adolescents: A comparative study between anorexia nervosa, normal weight, and obesity. 2026 · Clinica e investigacion en arteriosclerosis : publicacion oficial de la Sociedad Espanola de Arteriosclerosis · Panel: NMR low-molecular-weight metabolites
- A Robust Multivariate Approach Unveils a 1H-NMR-Based Spectral Metabolomics Signature Predictive of Cardiovascular Disease in People with Type 2 Diabetes: A Prospective Di@bet.es Cohort Study. 2025 · Journal of proteome research · Panel: NMR low-molecular-weight metabolites
- Effect of early initiation of empagliflozin with or without sacubitril/valsartan in a swine model of myocardial infarction 2025 · British Journal of Surgery · Panel: NMR low-molecular-weight metabolites
- 208: Metabolic profiling and targeted lipidomics in small for gestational age and fetal growth restriction 2019 · American Journal of Obstetrics and Gynecology · Panel: NMR low-molecular-weight metabolites
Related news
- NMR Metabolomics in Animal Models: A Key Tool for Translational Research 10 April 2025 · Panel: NMR low-molecular-weight metabolites
- Metabolomics in Sports: Applications in Performance and Recovery 24 October 2024 · Panel: NMR low-molecular-weight metabolites
- Role of Metabolomics in Infectious Diseases: A Cross-sectional Approach 19 September 2024 · Panel: NMR low-molecular-weight metabolites
Show 7 more Show less
- Desvelando Misterios de la Complejidad Lipoproteica en Diabetes Tipo 2 y Riesgo Cardiovascular 29 April 2024 · in Spanish · Panel: NMR low-molecular-weight metabolites
- Biosfer Teslab at the forefront of NMR sample analysis 26 March 2024 · Panel: NMR low-molecular-weight metabolites
- Exploring Metabolomics through Nuclear Magnetic Resonance and its Impact on Nutritional Interventions 13 February 2024 · Panel: NMR low-molecular-weight metabolites
- The Importance of Branched-Chain Amino Acids (BCAAs) in Metabolism Monitoring 08 February 2024 · Panel: NMR low-molecular-weight metabolites
- MetBalance test: Monitor your metabolic health and revolutionize the way you take care of yourself 29 January 2024 · Panel: NMR low-molecular-weight metabolites
- What is metabolomics and how is it applied in diabetes? 13 November 2023 · Panel: NMR low-molecular-weight metabolites
- Liposcale for early and reliable diagnosis and prognosis of breast cancer patients 08 September 2021 · Panel: NMR low-molecular-weight metabolites
Related projects
- DALÍ 2024 · Consortium coordinator · Panel: NMR low-molecular-weight metabolites
- AVANTE 2023 · Consortium coordinator · Panel: NMR low-molecular-weight metabolites
- HARMONi 2023 · Consortium coordinator · Panel: NMR low-molecular-weight metabolites
Show 7 more Show less
- COST Action AtheroNET 2022 · Consortium partner · Panel: NMR low-molecular-weight metabolites
- CARDIOSCOPE 2022 · Consortium partner · Panel: NMR low-molecular-weight metabolites
- Companion diagnostic for Saroglitazar 2021 · Beneficiary company · Panel: NMR low-molecular-weight metabolites
- Torres Quevedo · Colorectal cancer 2021 · Beneficiary company · Panel: NMR low-molecular-weight metabolites
- VISIONING 2021 · Co-principal investigator, with the IRB CatSud metabolomics platform · Panel: NMR low-molecular-weight metabolites
- Torres Quevedo · Diagnostic metabolomics 2020 · Beneficiary company · Panel: NMR low-molecular-weight metabolites
- Cardiometabolic prediction 2018 · Beneficiary company · Panel: NMR low-molecular-weight metabolites